Globus Medical Inc
GMED· NYSE
Released May 7, 2024, after the close
10-Q filed May 7, 2024, 37 days after period end · 0001562762-24-000126
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $606.67M | $276.69M | $230.55M | $227.34M |
| Net Income | -$7.12M | $49.13M | $38.08M | $45.33M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| -$0.05 |
| $0.48 |
| $0.37 |
| $0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.